The safety and integrity of the product matter just as much as the treatment itself, says Dr
Common: nausea (especially during dose increasesusually mild and transient), constipation or diarrhea, occasional vomiting, fatigue in first weeks, decreased appetite (the desired effect, but worth noting)
What's next: The Food and Drug Administration will hold a meeting this summer to consider easing the current restrictions on more than a half dozen peptide injections
In a healthy gastrointestinal tract, there are few bacteria in the small intestine
It helps neutralize free radicals and supports the body's ability to handle oxidative stress
All FDA-approved GLP-1 medications have demonstrated improved fasting blood glucose and HbA1c reductions compared to placebo